Lenire by Neuromod


Lenire by Neuromod is a breakthrough bimodal neuromodulation device that has been proven in three large-scale clinical trials and with real world patients to deliver clinically significant long-term relief from tinnitus. Lenire pairs sound and mild electrical pulses to the tongue to significantly reduce the brain’s focus on tinnitus in favour of new non-tinnitus auditory pathways. Landmark research for Lenire has been peer-reviewed and published in Nature, Science Translational Medicine, and The American Journal of Audiology. A recent review on real world patients treated with Lenire at an independent clinic found that 91% of patients had clinically significant relief from tinnitus. The groundbreaking device has achieved patient outcomes that have been featured in New Scientist, Bloomberg, NPR, Good Morning America, The Daily Mail, The Age and many more. Lenire is available through specialist tinnitus clinics across Europe, Australia, Canada, and the United States of America. You can find a nearby clinic and refer patients directly by visiting lenire.com/find-a-clinic.

Contact us by email at info@lenire.com or phone +353 1 253 1444

Privacy notice